Research desk · RMD · NYSE

SEC financials, peer compare, and chart. Scores open the matching desk. Research only — not advice.

ResMed Inc. · Surgical & Medical Instruments & Apparatus

ResMed Inc. financial statements, chart, and peer compare from SEC filings.

ResMed Inc. (RMD) provides medical devices, diagnostics, or healthcare products.

Market cap
$33.98B
P/E
24.00
Op. margin
33.61%
Profit margin
20.52%
FCF margin
10.96%
ROE
17.11%

Related Health Care stocks: DXCM stock financials · WST stock financials · EHC stock financials · ENSG stock financials · PODD stock financials

See Health Care moving on the anomaly desk

misprise.com
Exceptional (85–100) TTM Updated October 18, 2026 9:33 pm ← Screener
Primary research · 02

RMD financial statements

Each Compare name is its own block of years. Filing lines are SEC reports; P/E and price sit on that name’s TTM column only.

Primary research · 03

RMD stock peer compare

Each bar is that name’s percent vs its last TTM, on one zero line. Zero is unchanged. This ticker is the black bar.

Focus chart

Zero is unchanged vs last TTM. Every name is a percent for the metric you pick.

Supporting · 04

RMD stock peer headlines

Yahoo Finance RSS for RMD and the names in Compare.

Ticker Date Headline
Loading headlines…
Supporting · 05

RMD stock price chart

Overlays follow the Compare table.

Chart loads when you scroll here
Supporting · 06

RMD stock — research snapshot

Screen strengths and watchouts for RMD stock from the latest Misprise snapshot.

Strengths

  • ROA 12.6% — strong returns on assets.
  • Operating margin 33.6% — solid operating leverage.
  • Profit margin 20.5% — durable bottom-line quality.
  • FCF margin 11.0% — cash conversion looks healthy.
  • Revenue CAGR 5Y 12.1% — durable top-line compound.

Watchouts

  • No major red flags on the core screen — still read the filings on your own.
  • Rev CAGR 5Y 12.1%
  • Rev CAGR 3Y 10.2%
  • EPS CAGR 5Y 26.3%
  • EPS CAGR 3Y 19.6%
  • FCF CAGR 5Y 21.1%
  • FCF CAGR 3Y 42.2%
Supporting · 07

RMD stock FAQs

Short answers for RMD stock — statements, sector, and how this page is meant to be used.

What is RMD stock?

ResMed Inc. (RMD) provides medical devices, diagnostics, or healthcare products. RMD stock sits in Health Care (Surgical & Medical Instruments & Apparatus), listed on NYSE.

Where can I find ResMed Inc. financial statements?

ResMed Inc. financial statements — income statement, balance sheet, and cash flow — are on this RMD stock page, parsed from SEC 10-K and 10-Q filings. Use Annual or Quarterly, then the statement tabs. Research only.

What happened to RMD stock?

This page is a research snapshot of ResMed Inc. (RMD) from the latest SEC filings in the Misprise database as of TTM. It is not a news feed or a delisting notice. Open the financial statements, chart, and peer compare below, then read the filings. Research only — not financial advice.

Does this page show the RMD stock price?

The live chart on this RMD stock page is the same TradingView chart as the screener. Statement tables use SEC filings. Any price or multiple on the TTM column is a market snapshot from the last seed, not a real-time quote. Research only.

What sector is RMD stock in?

ResMed Inc. is classified in Surgical & Medical Instruments & Apparatus, inside the Health Care sector, and trades on NYSE. This page is a research snapshot, not a full company profile.

How do I read RMD financial statements?

Start with this ticker’s block (TTM, then its fiscal years or quarters). Each Compare name is a separate block of its own periods — not mixed by year. A blank is a period we do not have, not a zero. Research only — not a buy or sell.

Where does the RMD statement data come from?

Income, balance sheet, and cash-flow lines are parsed from SEC company filings (10-K / 10-Q and 20-F). TTM is the last four reported quarters added together, not a separate filing. P/E, forward P/E, price, and market cap are a market quote at last seed — trailing P/E from the quote when available, otherwise last price divided by TTM EPS. They are not 10-K line items and appear on the TTM column only. Research only — not financial advice.

Where can I find the RMD income statement, balance sheet, and cash flow?

On this RMD stock page, open Financial statements and use the Income, Balance sheet, and Cash flow tabs. Growth and valuation sit under More. Filing figures are from SEC reports; valuation multiples are the market snapshot described above.

What is the Misprise Score for RMD stock?

RMD stock currently scores 95/100 (Exceptional (85–100)). ResMed Inc. clears the high end of the Misprise screen — multi-year growth, profitability, and balance-sheet quality line up together. The score is a screen of quality, growth, and balance-sheet inputs — not a price target. Compare it in the Misprise screener; it is not a separate score page.

How is the RMD comparison winner decided?

Lead and Tie follow the number printed on each factor row, not a blended category score. Growth, quality, score, current ratio, and coverage: the higher figure leads. Value multiples (P/E, PEG, P/B, P/S) and debt ratios: the lower figure leads. Tie appears only when those printed numbers match. The header winner is whoever takes more of those five rows. CAGR uses the 5-year horizon and drops to 3-year only when both names report it. Research only — not a buy or sell.

What is the Anomaly Score on this RMD page?

Anomaly Score is how unusual a filing pattern is versus this company’s own history and its industry — not the same as Misprise Score. A high anomaly with a weak Misprise Score is often a noisy name. Open the anomaly detector to see the flag. Research only — not financial advice.

What does the green grant dot mean on RMD stock?

A green circle next to the title means this ticker appears in the Misprise grants calendar with a recent federal award (USASpending / SAM). Tap the dot for date, agency, and amount when available. It is a research flag only — not a buy or sell signal.

Is RMD stock a buy?

No recommendation either way. This RMD stock page organizes statements, ratios, and peers so you can do your own work. It is educational only — not advice to buy or sell ResMed Inc..